The genetic association of the transcription factor NPAT with glycemic response to metformin involves regulation of fuel selection.
The biguanide, metformin, is the first-choice therapeutic agent for type-2 diabetes, although the mechanisms that underpin metformin clinical efficacy remain the subject of much debate, partly due to the considerable variation in patient response to metformin. Identification of poor responders by ge...
Guardado en:
Autores principales: | Changwei Chen, Jennifer R Gallagher, Jamie Tarlton, Lidy van Aalten, Susan E Bray, Michael L J Ashford, Rory J McCrimmon, Ewan R Pearson, Alison D McNeilly, Calum Sutherland |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a24a180cc2645e98a6b2242015332ed |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lycopene Improves the Metformin Effects on Glycemic Control and Decreases Biomarkers of Glycoxidative Stress in Diabetic Rats
por: Figueiredo ID, et al.
Publicado: (2020) -
An introduction to biomolecular graphics.
por: Cameron Mura, et al.
Publicado: (2010) -
Metformin regulates glycemic homeostasis in patients with type 2 diabetes mellitus as an NO donor
por: Ivan Sergeevich Kuznetsov, et al.
Publicado: (2013) -
Metformin regulates glycemic homeostasis in patients with type 2 diabetes mellitus as an NO donor
por: Ivan Sergeevich Kuznetsov, et al.
Publicado: (2013) -
The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep.
por: Kirsten Hogg, et al.
Publicado: (2011)